Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorAssiut University

About this trial

The association of metabolic associated fatty liver disease in patients with chronic glomerular disease

Eligibility criteria

Qualifiers

All CKD patient aging between (18-70) years with known tubule-glomerular diseases.

At any eGFR.

All CKD patient have either type I/II DM associated with CKD .

Disqualifiers

CKD patients of Unknown etiology.

CKD patients with liver cirrhosis.

CKD patients secondry to documented diabetic nephropathy.

Patients with previous/current HBV or HCV.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators